AstraZeneca Dividends and Buybacks
Dividend criteria checks 4/6
AstraZeneca is a dividend paying company with a current yield of 2.19% that is well covered by earnings.
Key information
2.2%
Dividend yield
0.02%
Buyback Yield
| Total Shareholder Yield | 2.2% |
| Future Dividend Yield | 2.6% |
| Dividend Growth | -8.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | AR$3.011 |
| Payout ratio | 71% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: AZN's dividend payments have been volatile in the past 10 years.
Growing Dividend: AZN's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| AstraZeneca Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (AZN) | 2.2% |
| Market Bottom 25% (AR) | 0.6% |
| Market Top 25% (AR) | 2.9% |
| Industry Average (Pharmaceuticals) | 2.3% |
| Analyst forecast (AZN) (up to 3 years) | 2.6% |
Notable Dividend: AZN's dividend (2.19%) is higher than the bottom 25% of dividend payers in the AR market (0.57%).
High Dividend: AZN's dividend (2.19%) is low compared to the top 25% of dividend payers in the AR market (2.87%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (70.9%), AZN's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (66.1%), AZN's dividend payments are covered by cash flows.